https://www.pharmaradar360.com/article/7a7317006a545429PharmaRadar360en2026-04-08T11:32:50.000ZExdensur (depemokimab) approved in China for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP)https://www.pharmaradar360.com/article/3c8fa9f878fb648cPharmaRadar360en2026-04-08T10:00:00.000ZThe Ultimate Guide to New USP Bioburden Standards: Navigating Compliance & Market Success in 2026https://www.pharmaradar360.com/article/0735d31535df2708PharmaRadar360en2026-04-08T09:37:32.000ZDigital upgrade to histopathology service reduces wait time for cancer diagnosishttps://www.pharmaradar360.com/article/b529e0a735901334PharmaRadar360en2026-04-08T09:16:18.000ZFDA Seeks Input on Digital Health Technologies in Clinical Investigations for Drugs and Biological Productshttps://www.pharmaradar360.com/article/c5a3f9c98014ea0cPharmaRadar360en2026-04-08T07:00:10.000ZNotice Regarding Issuance of New Shares and Secondary Offering of Shareshttps://www.pharmaradar360.com/article/633d768b27b7df2ePharmaRadar360en2026-04-08T07:00:00.000ZNotice Regarding Refinancing of Existing Borrowings through a Bridge Loanhttps://www.pharmaradar360.com/article/9d0367961f54bf35PharmaRadar360en2026-04-08T02:00:00.000ZPharmac invites feedback before possible medicine brand changeshttps://www.pharmaradar360.com/article/1a7d6957c0fca353PharmaRadar360en2026-04-08T00:00:00.000ZShionogi Receives Contract with U.S. Government Through BARDA's Project BioShield to Enhance National Preparedness for Drug-Resistant Bacterial Threatshttps://www.pharmaradar360.com/article/78bb0fe214831903PharmaRadar360en2026-04-08T00:00:00.000ZESCMID Global 2026: Shionogi presents new real-world data highlighting clinical effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-producing Enterobacterales infectionshttps://www.pharmaradar360.com/article/6f6148bc4ab3c203PharmaRadar360en2026-04-08T00:00:00.000ZISPOR 2026 Plenaries and Speakers Announcedhttps://www.pharmaradar360.com/article/2e9a38805f5ff0d8PharmaRadar360en2026-04-08T00:00:00.000ZSome Common IBS Treatments Linked to Higher Risk of DeathApril08,2026 02:00 AMAmerica/Los_AngelesA large, long-term study led byCedars-Sinai Health Sciences…Read morehttps://www.pharmaradar360.com/article/3e8184c0c0b6e329PharmaRadar360en2026-04-07T20:01:00.000ZAmneal to Report First Quarter 2026 Results on May 1, 2026https://www.pharmaradar360.com/article/9408431688daa48fPharmaRadar360en2026-04-07T17:51:28.934ZEasy Ways to Spot Spring Allergieshttps://www.pharmaradar360.com/article/61b13122a190cac7PharmaRadar360en2026-04-07T16:00:00.000ZKennedy sidestepping court order sidelining ACIP?https://www.pharmaradar360.com/article/46d318d12d5b11cdPharmaRadar360en2026-04-07T15:46:23.000ZDecision: Human and veterinary medicines: register of licensed manufacturing siteshttps://www.pharmaradar360.com/article/3d3d773b50e88351PharmaRadar360en2026-04-07T15:45:00.000ZTransgene to Participate in Upcoming Investor Meetingshttps://www.pharmaradar360.com/article/36904b3f97761ee5PharmaRadar360en2026-04-07T15:25:08.000ZDecision: Medicines: new manufacturing and wholesale dealer licenceshttps://www.pharmaradar360.com/article/795c36db0193809dPharmaRadar360en2026-04-07T15:25:00.000ZNotice: Medicines: terminated and cancelled manufacturing and wholesale dealer licenceshttps://www.pharmaradar360.com/article/faed43e9e1789450PharmaRadar360en2026-04-07T15:24:49.000ZDecision: Human medicines: register of licensed wholesale distribution siteshttps://www.pharmaradar360.com/article/21a6edec1caf7afaPharmaRadar360en2026-04-07T15:11:58.000ZFind product information about medicineshttps://www.pharmaradar360.com/article/e1a37f7084840d78PharmaRadar360en2026-04-07T15:00:00.000ZSector tariff now more than a threat – for some Rx companieshttps://www.pharmaradar360.com/article/69a247d6c040ae71PharmaRadar360en2026-04-07T13:00:00.000ZMerck Begins Tender Offer to Acquire Terns Pharmaceuticals, Inc.https://www.pharmaradar360.com/article/498d71c381684fc9PharmaRadar360en2026-04-07T13:00:00.000ZAllergan Aesthetics Third State-of-the-Art AMI Center Opens in Austinhttps://www.pharmaradar360.com/article/5c3ff9f103b0677bPharmaRadar360en2026-04-07T12:30:00.000ZAbeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directorshttps://www.pharmaradar360.com/article/b73fdd388f8735ddPharmaRadar360en2026-04-07T12:05:00.000ZEmergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparednesshttps://www.pharmaradar360.com/article/22c8686631dc1d90PharmaRadar360en2026-04-07T12:00:00.000ZAmneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Monthhttps://www.pharmaradar360.com/article/db856c0240490cc2PharmaRadar360en2026-04-07T12:00:00.000ZNatac’s CEO presents SustaiNext as an example of industrial scale-up at the CBE JU Stakeholder Forum 202607/04/2026Industrial biotechnologyAntonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based…Partners - Natac Grouphttps://www.pharmaradar360.com/article/cdd7493356f30112PharmaRadar360en2026-04-07T11:11:33.000ZLa AEMPS recuerda las condiciones para obtener la licencia previa de funcionamiento para la fabricación a terceros de productos sanitarios y productos sanitarios para diagnóstico in vitrohttps://www.pharmaradar360.com/article/06a1c299ee5a17a2PharmaRadar360en2026-04-07T07:00:00.000ZSkye Bioscience Presenting at GLP-1-Based Therapeutics Summithttps://www.pharmaradar360.com/article/29ba8e8ec46822b2PharmaRadar360en2026-04-07T02:50:00.000ZThe hidden math behind satisfying can-crushing videoshttps://www.pharmaradar360.com/article/da80f94e3b694b92PharmaRadar360en2026-04-07T00:00:00.000ZResearch & Developmenthttps://www.pharmaradar360.com/article/f64678b8b4df4e06PharmaRadar360en2026-04-07T00:00:00.000ZUSP Revisions: What They Mean for Injectable Drug Quality and Why Packaging Matters More Than Everhttps://www.pharmaradar360.com/article/a3d932d8145cb946PharmaRadar360en2026-04-07T00:00:00.000ZRead the Press Releasehttps://www.pharmaradar360.com/article/e5840ce00f2ffef9PharmaRadar360en2026-04-07T00:00:00.000ZTuHURA Biosciences, Inc.https://www.pharmaradar360.com/article/3c2291e9509c4c63PharmaRadar360en2026-04-07T00:00:00.000Ztuhura biosciences appoints amanda garofalo mshs as senior vice president of clinical operations 302735470https://www.pharmaradar360.com/article/eaa9007bf360d765PharmaRadar360en2026-04-07T00:00:00.000ZPharming Group to participate in April investor conferencesConference attendanceApril 7 2026Pharming Group N.V. today announced that its management will participate in the following investor conferences in the month of April:Read morehttps://www.pharmaradar360.com/article/11c35d24d5834c31PharmaRadar360en2026-04-07T00:00:00.000ZPharmacists at Orion – The many paths a pharmacy degree can open up in the pharmaceutical industry4/7/2026 We are Orion Pharmahttps://www.pharmaradar360.com/article/30180204a79fe025PharmaRadar360en2026-04-07T00:00:00.000ZPharma Research & Developmenthttps://www.pharmaradar360.com/article/fafc8d888e90b0aaPharmaRadar360en2026-04-07T00:00:00.000ZIR and Shareholder Contactshttps://www.pharmaradar360.com/article/7c3c887a6f1e163ePharmaRadar360en2026-04-07T00:00:00.000Znatco receives approval from central drug standard control organisation cdsco for semaglutide in indiahttps://www.pharmaradar360.com/article/2570cc332712ccddPharmaRadar360en2026-04-07T00:00:00.000Znatco pharma limited api unit in chennai receives establishment inspection report eir from u s fdahttps://www.pharmaradar360.com/article/4ab17373e80361e9PharmaRadar360en2026-04-07T00:00:00.000Znatco pharma launches semaglutide generic injection multi dose vials in india at the most affordable price starting from mrp inr 1290https://www.pharmaradar360.com/article/79162b6bbd567300PharmaRadar360en2026-04-07T00:00:00.000Znatco announces launch of pomalidomide capsules generic of pomalyst in the u s markethttps://www.pharmaradar360.com/article/20171ad0cd160930PharmaRadar360en2026-04-07T00:00:00.000Znatco announces launch of its everolimus tablets 1 mg generic of zortresshttps://www.pharmaradar360.com/article/c31d74752418754fPharmaRadar360en2026-04-07T00:00:00.000Zintimation under regulation 30 of sebi listing obligations and disclosure requirements regulations 2015 2https://www.pharmaradar360.com/article/70bd8573fcd9db24PharmaRadar360en2026-04-07T00:00:00.000Zdisclosure under regulation 30 of the sebi listing obligations and disclosure requirements regulations 2015https://www.pharmaradar360.com/article/191dcccfdbe434dcPharmaRadar360en2026-04-07T00:00:00.000Zadcock ingram completes delisting from jse natco pharma acquires 35 75 stakehttps://www.pharmaradar360.com/article/017bd5fd197d16e3PharmaRadar360en2026-04-07T00:00:00.000ZISPOR Publishes Recommendations on Valuing Child and Adolescent Health for Economic Evaluationshttps://www.pharmaradar360.com/article/d5d1724a5634faa6PharmaRadar360en2026-04-07T00:00:00.000ZGilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipelinehttps://www.pharmaradar360.com/article/aad7ffbb74c89147PharmaRadar360en2026-04-07T00:00:00.000ZThe Analytical Scientist: Vibe Coding Comes to Omicshttps://www.pharmaradar360.com/article/db2fcbe9469635c7PharmaRadar360en2026-04-07T00:00:00.000ZSpot the phish in less than five minuteshttps://www.pharmaradar360.com/article/bab26f4bff950c9aPharmaRadar360en2026-04-07T00:00:00.000ZCell & Gene Covers the “Challenges with Implementing Annex 1 at the Global Level” Session from the 2026 ISPE Aseptic Conferencehttps://www.pharmaradar360.com/article/5699bcb7e99adc87PharmaRadar360en2026-04-07T00:00:00.000ZNuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLChttps://www.pharmaradar360.com/article/d9cda0008ef93b04PharmaRadar360en2026-04-07T00:00:00.000Zacadia pharmaceuticals announces daybue stix trofinetide is now broadly available in the united states for the treatment of rett syndromehttps://www.pharmaradar360.com/article/9312d49da9772aa5PharmaRadar360en2026-04-07T00:00:00.000ZWorld Health Day 2026: unite for health and stand with sciencehttps://www.pharmaradar360.com/article/5f43b9b414f8a1d3PharmaRadar360en2026-04-07T00:00:00.000ZMessage from Dr Hanan Balkhy WHO Regional Director for the Eastern Mediterranean on the occasion of World Health Dayhttps://www.pharmaradar360.com/article/7a32246ae763a3b5PharmaRadar360en2026-04-06T18:13:08.778ZHow To Start Your Morning With Less Stress